Live Breaking News & Updates on Patients With Liver Cirrhosis

Stay updated with breaking news from Patients with liver cirrhosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis

Taiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in patients. ....

T Ai Pei , Chiao Tung University , Xinzhu Xian , Cheng Chung Wei , Clin Gastroenterol Hepatol , National Yang Ming Chiao Tung University , National Health Insurance Research Database Of Taiwan , Chii Min Hwu , National Health Insurance Research Database , Agonist Use , Patients With Liver Cirrhosis , Clin Gastroenterol , Clinical Gastroenterology And Hepatology , Cardiovascular Events , Type 2 Diabetes , Liver Failure , Hepatic Encephalopathy , Lucagon Like Peptide1 Receptor Agonist , Decompensated Cirrhosis ,